This inventor holds 1 USPTO granted patent. Top assignee: University of Utah Research Foundation. Active years: 1998.
Company Filing History:
Years Active: 1998
Title: Michelle M Grilley: Innovator in Conotoxin Peptides
Introduction
Michelle M Grilley is a prominent inventor based in Salt Lake City, UT (US). She has made significant contributions to the field of biochemistry, particularly in the study of conotoxin peptides. Her work focuses on the development of novel compounds that have potential therapeutic applications.
Latest Patents
Michelle M Grilley holds a patent for a specific conotoxin peptide, known as .delta.-conotoxin PVIA. This invention is directed to a peptide with the formula Glu-Ala-Cys-Tyr-Ala-Xaa.sub.1 -Gly-Thr-Phe-Cys-Gly-Ile-Lys-Xaa.sub.2 -Gly-Leu-Cys-Cys-Ser-Glu-Phe-Cys-Leu-Pro-Gly-Val-Cys-Pro-Gly, where Xaa.sub.1 or Xaa.sub.2 can be Pro or 4-trans-hydroxyproline. The C-terminus of this conotoxin may be free or amidated. This vertebrate-specific conotoxin targets voltage-sensitive sodium channels, showcasing its potential in medical applications.
Career Highlights
Michelle is affiliated with the University of Utah Research Foundation, where she conducts her research. Her work has garnered attention for its innovative approach to understanding and utilizing conotoxins in therapeutic contexts.
Collaborations
Throughout her career, Michelle has collaborated with notable scientists, including Ki-Joon Shon and Baldomero M Olivera. These collaborations have contributed to the advancement of research in the field of conotoxin peptides.
Conclusion
Michelle M Grilley is a distinguished inventor whose work on conotoxin peptides has the potential to impact medical science significantly. Her contributions to the field exemplify the importance of innovation in biochemistry.